Prelude Therapeutics (PRLD) Net Equity Issued and Repurchased (2021 - 2026)
Prelude Therapeutics (PRLD) recorded Net Equity Issued and Repurchased of $85,000 in Q2 2026, down 7.6% from $92,000 a year earlier but up 174.2% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
On a TTM basis, Prelude Therapeutics' Net Equity Issued and Repurchased came in at $174,000 as of Jun 30, 2026, down 19.4% year-over-year; for FY2025, it was $150,000, down 60.4% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -75.4% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $379,000 in FY2024 (-40.2%), $634,000 in FY2023 (+48.8%), $426,000 in FY2022 (-99.7%) and $161.42 million in FY2021 (-3.1%).
- Quarterly Net Equity Issued and Repurchased has ranged from $2,000 in Q1 2024 to $320,000 in Q2 2023 over the past five years.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 333.3% in Q4 2023, against a decline of 99.9% in Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Prelude Therapeutics | 312.03 Mn | -285.27 Mn | - | 85,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 58,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Jun 30, 2024 | 253,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 286,000.00 |
| Jun 30, 2023 | 320,000.00 |
| Mar 31, 2023 | 28,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 147,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Mar 31, 2021 | 161.42 Mn |
API Access
Prelude Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();